Covid vaccine: Covaxin effective even after 3 months

Covid vaccine: Covaxin effective even after 3 months

Earlier this month, based on interim phase 3 data, Bharat Biotech had reported a 81% efficacy for Covaxin. Data from a follow-up to the phase I trials of Bharat Biotech’s Covaxin shows that the immune response to the vaccine generated neutralising antibodies that remained elevated even three months after the receipt of the second dose. … Read more

Covaxin interim efficacy very good, awaiting more data and full results: Dr Gagandeep Kang

Covaxin interim efficacy very good, awaiting more data and full results: Dr Gagandeep Kang

These countries are highly satisfied with the safe, inactivated vaccine technology and robust data package for safety and immunogenicity.” The much-awaited result from the phase 3 clinical trials of Covaxin, the vaccine that has been granted emergency use authorization under a trial mode, is finally out and the news seems encouraging. What is however awaited … Read more